ClinicalTrials.Veeva

Menu
H

HD Research LLC | First Surgical Hospital

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Acetaminophen
Ibuprofen
HTX-011
Bupivacaine Hydrochloride
Bupivacaine
VX-548
Bupivacaine HCl
CNTX-4975-05
UBX0101
Celecoxib

Parent organization

This site is a part of HD Research LLC

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 20 total trials

A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease (VIVID-2)

The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.

Enrolling
Crohn's Disease
Drug: Mirikizumab

This is a Phase 4, randomized, blinded, active-controlled, multicohort study to evaluate HTX-011 compared with bupivacaine HCl in subjects undergoing...

Active, not recruiting
Analgesia
Drug: Acetaminophen
Drug: HTX-011

This study will evaluate the safety, efficacy, and PK of low dose (750 mg) and high-dose (1250 mg) XG005 oral tablets compared with placebo in subjec...

Enrolling
Acute Pain
Drug: XG005 tablet
Drug: Placebo tablet

Trial sponsors

H
Pacira logo
C
Vertex Pharmaceuticals logo
C
I
Johnson & Johnson (J&J) logo
Lilly logo
Pacira logo
U

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems